Latest Insider Transactions at Vyne Therapeutics Inc. (VYNE)
This section provides a real-time view of insider transactions for Vyne Therapeutics Inc. (VYNE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VYNE Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VYNE Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2021
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
153,750
+24.27%
|
-
|
|
Feb 22
2021
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
BUY
Grant, award, or other acquisition
|
Direct |
29,213
+20.89%
|
-
|
|
Feb 22
2021
|
Andrew Saik Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,213
+20.37%
|
-
|
|
Feb 22
2021
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
29,213
+22.47%
|
-
|
|
Feb 22
2021
|
Matthew T. Wiley Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,675
+19.13%
|
-
|
|
Jan 28
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,219,409
+13.47%
|
$8,438,818
$2.37 P/Share
|
|
Dec 31
2020
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,656
-0.73%
|
$9,656
$1.58 P/Share
|
|
Dec 31
2020
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,822
-0.56%
|
$1,822
$1.58 P/Share
|
|
Dec 31
2020
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,378
-0.82%
|
$2,378
$1.58 P/Share
|
|
Dec 31
2020
|
Matthew T. Wiley Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,541
-0.43%
|
$1,541
$1.58 P/Share
|
|
Dec 03
2020
|
Patrick G Lepore Director |
BUY
Open market or private purchase
|
Direct |
50,000
+50.0%
|
$50,000
$1.71 P/Share
|
|
Nov 30
2020
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,263
+0.32%
|
$4,263
$1.45 P/Share
|
|
Nov 30
2020
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
BUY
Grant, award, or other acquisition
|
Direct |
10,460
+3.09%
|
$10,460
$1.45 P/Share
|
|
Nov 30
2020
|
Matthew T. Wiley Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,838
+2.14%
|
$7,838
$1.45 P/Share
|
|
Sep 30
2020
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,239
-0.47%
|
$6,239
$1.66 P/Share
|
|
Sep 30
2020
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,822
-0.57%
|
$1,822
$1.66 P/Share
|
|
Sep 30
2020
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,378
-0.82%
|
$2,378
$1.66 P/Share
|
|
Sep 30
2020
|
Matthew T. Wiley Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,541
-0.44%
|
$1,541
$1.66 P/Share
|
|
Jun 09
2020
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,702,702
+10.57%
|
$2,702,702
$1.85 P/Share
|